As we age, our cells accumulate genetic changes—mutations—some of which open the door to cancer. Scientists call these ...
After collecting an FDA approval earlier this year for local pancreatic cancer, Novocure is putting forward positive clinical data for its electric field-based treatment in metastatic cases of the ...
Chronic pancreatitis (CP), long considered a simple alcoholic disease, is now recognized as a complex fibro-inflammatory syndrome involving the interaction of multiple factors. This new perspective is ...
DENVER — A Lafayette father with stage 4 pancreatic cancer is believed to be the first patient in Colorado to receive a newly approved targeted therapy. Colin Kiesel recently started taking ...
Hosted on MSN
5 signs your pancreas isn’t working correctly
Your pancreas may be small, but it is extremely important when it comes to keeping us healthy. Here are five signs that your pancreas isn’t working correctly. Pain in your abdomen can be a sign of ...
Carolyn Gusoff has covered some of the most high profile news stories in the New York City area and is best known as a trusted, tenacious, consistent and caring voice of Long Island's concerns. For ...
Researchers headed by a team at NYU Langone Health have discovered that a feature of pancreatic cancer cells’ surroundings determines whether they grow fast or become resistant to chemotherapy. The ...
FDA approved Optune Pax with gemcitabine/nab-paclitaxel, applying alternating electric fields to disrupt mitosis via abdominal arrays, expanding noninvasive, home ...
Share on Pinterest Could an experimental drug trio fight difficult-to-treat pancreatic cancer? Experiments in mouse models show promise. Image credit: adamkaz/Getty Images Pancreatic ductal ...
Current drugs for pancreatic cancer lose effectiveness within months because the tumor becomes resistant. Now, a group from Spain's National Cancer Research Centre (CNIO) has been able to avoid the ...
New research uncovered a potential new way to treat pancreatic cancer, the third-deadliest cancer in 2025. The therapy may help human immune cells more effectively attack pancreatic tumors. Below, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results